MAMU
HALO icon

Myriad Asset Management US’s Halozyme HALO Stock Holding History

Myriad Asset Management US’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-77,000
Closed -$3.39M – 33
2022
Q2 		$3.39M Buy
+77,000
New +$3.33M 0.78% 19

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Myriad Asset Management US's HALO Position: Q3 2022 in Review

Myriad Asset Management US sold out of Halozyme (HALO) in Q3 2022, closing a stake of 77,000 shares — an estimated $3.39M sold.

Myriad Asset Management US first reported a position in HALO in Q2 2022 and held it in 1 quarter. The position peaked at $3.39M in Q2 2022. 357 funds tracked by Wall St. Rank hold HALO as of Q3 2022.

  • Myriad Asset Management US reported no remaining Halozyme position as of Q3 2022 after selling out during the quarter.
  • Myriad Asset Management US sold 77,000 Halozyme shares in Q3 2022, an estimated $3.39M.
  • Myriad Asset Management US first reported a position in Halozyme in Q2 2022 and held it in 1 quarter.
  • Myriad Asset Management US's Halozyme position peaked at $3.39M in Q2 2022.
  • 357 funds tracked by Wall St. Rank held Halozyme as of Q3 2022.

Based on Myriad Asset Management US's 13F filing for Q3 2022, filed 14 Nov 2022.